201 related articles for article (PubMed ID: 12067895)
1. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism.
Kaneider NC; Egger P; Dunzendorfer S; Noris P; Balduini CL; Gritti D; Ricevuti G; Wiedermann CJ
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):894-900. PubMed ID: 12067895
[TBL] [Abstract][Full Text] [Related]
2. Rho-GTPase-dependent platelet-neutrophil interaction affected by HMG-CoA reductase inhibition with altered adenosine nucleotide release and function.
Kaneider NC; Egger P; Dunzendorfer S; Wiedermann CJ
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):1029-35. PubMed ID: 12067916
[TBL] [Abstract][Full Text] [Related]
3. Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes.
Koziak K; Sévigny J; Robson SC; Siegel JB; Kaczmarek E
Thromb Haemost; 1999 Nov; 82(5):1538-44. PubMed ID: 10595651
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of thrombin-induced signaling by resveratrol and quercetin: effects on adenosine nucleotide metabolism in endothelial cells and platelet-neutrophil interactions.
Kaneider NC; Mosheimer B; Reinisch N; Patsch JR; Wiedermann CJ
Thromb Res; 2004; 114(3):185-94. PubMed ID: 15342215
[TBL] [Abstract][Full Text] [Related]
5. Role of extracellular ATP metabolism in regulation of platelet reactivity.
Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
[TBL] [Abstract][Full Text] [Related]
6. Suppression of ATP diphosphohydrolase/CD39 in human vascular endothelial cells.
Imai M; Kaczmarek E; Koziak K; Sévigny J; Goepfert C; Guckelberger O; Csizmadia E; Schulte Am Esch J; Robson SC
Biochemistry; 1999 Oct; 38(41):13473-9. PubMed ID: 10521254
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
8. CD39 modulates endothelial cell activation and apoptosis.
Goepfert C; Imai M; Brouard S; Csizmadia E; Kaczmarek E; Robson SC
Mol Med; 2000 Jul; 6(7):591-603. PubMed ID: 10997340
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of CD39/vascular ATP diphosphohydrolase.
Kaczmarek E; Koziak K; Sévigny J; Siegel JB; Anrather J; Beaudoin AR; Bach FH; Robson SC
J Biol Chem; 1996 Dec; 271(51):33116-22. PubMed ID: 8955160
[TBL] [Abstract][Full Text] [Related]
10. Perindopril augments ecto-ATP diphosphohydrolase activity and enhances endothelial anti-platelet function in human umbilical vein endothelial cells.
Kishi Y; Ohta S; Kasuya N; Sakita SY; Ashikaga T; Isobe M
J Hypertens; 2003 Jul; 21(7):1347-53. PubMed ID: 12817183
[TBL] [Abstract][Full Text] [Related]
11. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin.
Jacobson JR; Dudek SM; Birukov KG; Ye SQ; Grigoryev DN; Girgis RE; Garcia JG
Am J Respir Cell Mol Biol; 2004 May; 30(5):662-70. PubMed ID: 14630613
[TBL] [Abstract][Full Text] [Related]
12. Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity.
Schulte am Esch J; Sévigny J; Kaczmarek E; Siegel JB; Imai M; Koziak K; Beaudoin AR; Robson SC
Biochemistry; 1999 Feb; 38(8):2248-58. PubMed ID: 10029517
[TBL] [Abstract][Full Text] [Related]
13. Statins blunt thrombin-induced down-regulation of endothelial nitric oxide synthase expression in human endothelial cells.
Eto M; Rathgeb L; Cosentino F; Kozai T; Lüscher TF
J Cardiovasc Pharmacol; 2006 May; 47(5):663-7. PubMed ID: 16775505
[TBL] [Abstract][Full Text] [Related]
14. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Alyonycheva TN; Safier LB; Hajjar KA; Posnett DN; Schoenborn MA; Schooley KA; Gayle RB; Maliszewski CR
J Clin Invest; 1997 Mar; 99(6):1351-60. PubMed ID: 9077545
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
Gayle RB; Maliszewski CR; Gimpel SD; Schoenborn MA; Caspary RG; Richards C; Brasel K; Price V; Drosopoulos JH; Islam N; Alyonycheva TN; Broekman MJ; Marcus AJ
J Clin Invest; 1998 May; 101(9):1851-9. PubMed ID: 9576748
[TBL] [Abstract][Full Text] [Related]
16. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis.
Glenn JR; White AE; Johnson AJ; Fox SC; Myers B; Heptinstall S
Platelets; 2008 Feb; 19(1):59-69. PubMed ID: 18231939
[TBL] [Abstract][Full Text] [Related]
17. CD39 as a caveolar-associated ectonucleotidase.
Kittel A; Kaczmarek E; Sevigny J; Lengyel K; Csizmadia E; Robson SC
Biochem Biophys Res Commun; 1999 Sep; 262(3):596-9. PubMed ID: 10471369
[TBL] [Abstract][Full Text] [Related]
18. Placental ecto-ATP diphosphohydrolase: its structural feature distinct from CD39, localization and inhibition on shear-induced platelet aggregation.
Makita K; Shimoyama T; Sakurai Y; Yagi H; Matsumoto M; Narita N; Sakamoto Y; Saito S; Ikeda Y; Suzuki M; Titani K; Fujimura Y
Int J Hematol; 1998 Oct; 68(3):297-310. PubMed ID: 9846014
[TBL] [Abstract][Full Text] [Related]
19. Cerivastatin reduces cytokine-induced surface expression of ICAM-1 via increased shedding in human endothelial cells.
Landsberger M; Wolff B; Jantzen F; Rosenstengel C; Vogelgesang D; Staudt A; Dahm JB; Felix SB
Atherosclerosis; 2007 Jan; 190(1):43-52. PubMed ID: 16529752
[TBL] [Abstract][Full Text] [Related]
20. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways.
Eto M; Kozai T; Cosentino F; Joch H; Lüscher TF
Circulation; 2002 Apr; 105(15):1756-9. PubMed ID: 11956113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
